Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Sep 2025 value amounting to 0.60.

  • Arrowhead Pharmaceuticals' Asset Utilization Ratio rose 2689.53% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 2689.53%. This contributed to the annual value of 0.66 for FY2025, which is 17525.28% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.60 for Q3 2025, which was up 58.67% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Asset Utilization Ratio registered a high of 0.60 during Q3 2025, and its lowest value of -0.02 during Q3 2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Asset Utilization Ratio value was 0.30 (recorded in 2023), while the average stood at 0.23.
  • In the last 5 years, Arrowhead Pharmaceuticals' Asset Utilization Ratio crashed by 108.71% in 2024 and then skyrocketed by 4,654.52% in 2025.
  • Arrowhead Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.21 in 2021, then soared by 64.15% to 0.35 in 2022, then decreased by 25.72% to 0.26 in 2023, then crashed by 108.71% to -0.02 in 2024, then surged by 2,689.53% to 0.60 in 2025.
  • Its Asset Utilization Ratio was 0.60 in Q3 2025, compared to 0.38 in Q2 2025 and 0.41 in Q1 2025.